Free press releases distribution network?

Agency / Source: STEMCELL Technologies, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



New PneumaCult™-ALI Medium for Air-Liquid Interface Culture of Bronchial Epithelial Cells - A new culture medium for more physiologically relevant differentiation of human bronchial epithelial cells has been released by STEMCELL Technologies - Stemcell.com
New PneumaCult™-ALI Medium for Air-Liquid Interface Culture of Bronchial Epithelial Cells

 

PRZOOM - /newswire/ - Vancouver, British Columbia, Canada, 2012/06/06 - A new culture medium for more physiologically relevant differentiation of human bronchial epithelial cells has been released by STEMCELL Technologies - Stemcell.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Cells cultured with PneumaCult™-ALI at the air-liquid interface (ALI) undergo extensive mucociliary differentiation to form a pseudostratified epithelium that closely resembles the human airway.

“Culturing primary human bronchial epithelial cells at the ALI using current methods often results in unsatisfactory and inconsistent differentiation”, commented Michael Riedel, a Scientist at STEMCELL Technologies. “Importantly, the morphology of cultures grown in PneumaCult™-ALI more closely and more consistently resemble the human airway, compared to other formulations”. Differentiated PneumaCult™-ALI cultures display highly motile cilia, produce and secrete mucus, and develop stable transepithelial electrical resistance.

The development of convenient, yet physiologically relevant in vitro culture systems is critical to research and development on chronic respiratory diseases such as asthma or COPD, and could accelerate the development of inhaled drug formulations. STEMCELL Technologies is proud to support respiratory research with new PneumaCult™-ALI. For more information about PneumaCult™-ALI, please watch our short video or visit our product page.

Contact
Kristy Favell, MSc, Product Manager
STEMCELL Technologies Inc
P: 604-668-0875

About STEMCELL Technologies

STEMCELL Technologies, Inc. (stemcell.com) is a leader in the development and marketing of specialty cell culture media, cell separation products and ancillary reagents for life science research. Driven by science and enabled by close interactions with global leaders in cell biology and medicine, STEMCELL delivers over 1000 products to research scientists in more than 70 countries worldwide. As “Scientists Helping Scientists,” STEMCELL delivers over 1000 products to more than 70 countries worldwide and provides leadership with services including hands-on training courses, proficiency testing, and contract services. To learn more about how STEMCELL helps to make research work, visit .

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: STEMCELL Technologies, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


New PneumaCult™-ALI Medium for Air-Liquid Interface Culture of Bronchial Epithelial Cells

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
STEMCELL Technologies |
Contact: Simon Hilcove - Stemcell.com 
604-675-7898 simon.hilcove[.]stemcell.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any STEMCELL Technologies, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From STEMCELL Technologies, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today